Convalescent Antibodies Infusion in COVID 19 Patients

Conditions:   Pneumonia, Viral;   Corona Virus Infection Intervention:   Biological: Anti-coronavirus antibodies (immunoglobulins) obtained with DFPP form convalescent patients Sponsors:   Piero Luigi Ruggenenti;   Aferetica Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

Authors: Massabeti R, Cipriani MS, Valenti I Abstract At the end of December 2019, the Health Commission of the city of Wuhan, China, alerted the World Health Organization (WHO) to a pneumonia cluster in the city. The cause was identified as being a new virus, later named SARS-CoV-2. We can distinguish three clinical phases of the disease with a distinct pathogenesis, manifestations and prognosis. Here, we describe the case of a 45-year-old male, successfully treated for Coronavirus disease (COVID-19). The patient was feeling sick in early April 2020; he had a fever and pharyngodynia. When he came to our COVID hosp...
Source: Journal of Population Therapeutics and Clinical Pharmacology - Category: Drugs & Pharmacology Tags: J Popul Ther Clin Pharmacol Source Type: research
Source: Reuters: Health - Category: Consumer Health News Source Type: news
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak is spreading worldwide. To date, no specific treatment has convincingly demonstrated its efficacy. Hydroxychloroquine and lopinavir/rit...
Source: Critical Care - Category: Intensive Care Authors: Tags: Research Source Type: research
The rapid spread of coronavirus disease 2019 (COVID-19) was declared as an emerging public health threat by the World Health Organization. As various measures have been taken successfully to combat the epidemi...
Source: BMC Infectious Diseases - Category: Infectious Diseases Authors: Tags: Case report Source Type: research
Idlibschools close; new outbreak promptsHong Kong to close all schools; Bolivia leader and Venezuelan Socialist party bosstest positiveIdlib ’s first Covid-19 case sparks fear of fresh disasterScott Morrison says Australia will halve rate of international arrivalsWHO inquiry aims to ‘stop the world being blindsided again’Disney World set to reopen despite coronavirus surge in FloridaUK coronavirus updates – live5.23pmBSTMike Ryan, head of the World Health Organization ’s emergencies programme, said on Friday that an outbreak of pneumonia in Kazakhstan, reported to be highly lethal, was “...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak World news UK news US news Australia news Science Infectious diseases Africa Source Type: news
Kazakhstan's health officials on Friday dismissed a Chinese claim that the Central Asian country is facing an outbreak of pneumonia more deadly than the new coronavirus.
Source: CBC | Health - Category: Consumer Health News Tags: News/Health Source Type: news
More than 32,000 cases of the 'unknown pneumonia' have been reported in Kazakhstan from June 29 to July 5, along with 451 deaths compared to 53,021 coronavirus cases and 296 deaths.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
The SARS-COV-2 is a novel coronavirus that has been identified after an outbreak of unusual pneumonia in Wuhan, China.
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Complications of Treatment Source Type: research
AbstractShenzhen is a city of 22 million people in south China that serves as a financial and trade center for East Asia. The city has extensive ties to Hubei Province, the first reported  epicenter of the coronavirus disease 2019 (COVID-19) outbreak in the world. Initial predictions suggested Shenzhen would experience a high number of COVID-19 cases. These predictions have not materialized. As of 31 March 2020 Shenzhen had only 451 confirmed cases of COVID-19. Contact tracing has shown that no cases were the result of community transmission within the city. While Shenzhen did not implement a citywide lockdo...
Source: Infectious Diseases of Poverty - Category: Infectious Diseases Source Type: research
Coronavirus disease 2019 (COVID-19), the seventh human coronavirus infectious disease, was first reported in Wuhan, China, in December 2019, followed by its rapid spread globally (251,059 deaths, on May 5, 2020, by Johns Hopkins University). An early clinical report showed that fever, cough, fatigue, sputum production, and myalgia were initial symptoms, with the development of pneumonia as the disease progressed. Increases in the level of serum liver enzymes, D-dimer, cardiac troponin I, and creatinine have been observed in severely ill patients, indicating that multiple organ failure had occurred in these cases. Lymphopen...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Coronavirus | COVID-19 | Pneumonia | Research